TransMedics (TMDX) Operating Margin Growth (3y) (2021 - 2026)
TransMedics (TMDX) Operating Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 2,016.00 |
| 10 | TransMedics | 2.51 Bn | 2.05 Bn | 101.16 Mn | 1,267.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,267.00 |
| Dec 31, 2025 | 3,484.00 |
| Sep 30, 2025 | 3,779.00 |
| Jun 30, 2025 | 7,072.00 |
| Mar 31, 2025 | 7,812.00 |
| Dec 31, 2024 | 13,968.00 |
| Sep 30, 2024 | 22,195.00 |
| Jun 30, 2024 | 12,480.00 |
| Mar 31, 2024 | 9,803.00 |
| Dec 31, 2023 | 8,051.00 |
| Sep 30, 2023 | 1,517.00 |
| Jun 30, 2023 | 19,866.00 |
| Mar 31, 2023 | 10,144.00 |
| Dec 31, 2022 | 12,193.00 |
| Sep 30, 2022 | 7,893.00 |
| Jun 30, 2022 | 8,850.00 |
| Mar 31, 2022 | 6,850.00 |
| Dec 31, 2021 | 4,692.00 |
| Sep 30, 2021 | -12,082.00 |
| Jun 30, 2021 | 6,302.00 |